IM Cannabis Corp. Files $50 Million Shelf Registration Statement

IM Cannabis Corp ( (IMCC) ) has shared an announcement.

On July 11, 2025, IM Cannabis Corp. announced the filing and effectiveness of a shelf registration statement on Form F-3 with the SEC. This registration allows the company to offer and sell up to $50 million of its securities, including common shares and warrants, subject to market conditions and capital needs. The announcement signifies IM Cannabis Corp.’s strategic move to potentially access capital markets and raise future financing, which could impact its operations and industry positioning.

The most recent analyst rating on (IMCC) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.

Spark’s Take on IMCC Stock

According to Spark, TipRanks’ AI Analyst, IMCC is a Neutral.

IM Cannabis Corp’s stock score is driven primarily by significant improvements highlighted in the earnings call, especially in the German market, and positive technical momentum. However, financial performance remains weak, with ongoing losses and high leverage. Valuation concerns with a negative P/E ratio further weigh down the score.

To see Spark’s full report on IMCC stock, click here.

More about IM Cannabis Corp

IM Cannabis Corp. is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany. The company focuses on sustainable and profitable growth in these high-value markets, leveraging a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. IMC operates through subsidiaries in Israel and Adjupharm GmbH in Germany, distributing cannabis to medical patients and pharmacies.

Average Trading Volume: 266,865

Technical Sentiment Signal: Hold

Current Market Cap: $10.95M

See more insights into IMCC stock on TipRanks’ Stock Analysis page.